The Effect of Mucositis Care Training Given to Caregivers in Pediatric Leukemia Cases on Mucosal Barrier Damage
NCT ID: NCT04813783
Last Updated: 2023-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2021-05-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Many national and international organizations have emphasized the responsibility of the nurse in patient education and stated it in the relevant laws and regulations.
The regulations focus on the educative role of the nurse for patients. In pediatric oncology clinics where leukaemia treatment and care is provided, the educational role of the nurse is directed towards the child individual and their family, and determining and meeting the educational needs of the whole family is vital in the nursing management of the child with cancer.
In this context, this study aims to examine the effect of mucositis care training to caregivers of pediatric patients aged 2 to 18 years, on the development of mucositis and the clinic's "mucosal barrier damage, laboratory-confirmed bloodstream infections".
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Education Given on Preventing Mouth Ulcers in Women With Breast Cancer
NCT07042568
The Effect of Nursing Education on Oral Mucositis in Bone Marrow Transplant Patients
NCT05705622
Providing Web-based Training to Parents Of Children With Leukemia
NCT06357585
Digital Training Module for Sustainable Education of Pediatric Oncology Nurses
NCT06562517
Training With Mobile Application in Breast Cancer
NCT04315012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Gastrointestinal mucositis (GM) can be defined as inflammation or ulceration in the gastrointestinal organs due to chemotherapy treatment. Symptoms of GM include abdominal pain, diarrhoea, bleeding, fatigue, malnutrition, dehydration, electrolyte imbalance, and secondary infections. GM can present in two forms as oral and anal mucositis. Both oral and anal all GMs have negative effects on growth and development in children. One of the main issues of the remedial approach in this regard is the provision of qualified mucositis care. There are studies in the literature that include parent training for the prevention and care of mucositis.
Many national and international organizations have emphasized the responsibility of the nurse in patient education and stated it in the relevant laws and regulations. The regulations focus on the educative role of the nurse for patients. In pediatric oncology clinics where leukaemia treatment and care is provided, the educational role of the nurse is directed towards the child individual and their family, and determining and meeting the educational needs of the whole family is vital in the nursing management of the child with cancer.
In this context, this study aims to examine the effect of mucositis care training to caregivers of pediatric patients aged 2 to 18 years, on the development of mucositis and the clinic's "mucosal barrier damage, laboratory-confirmed bloodstream infections".
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The first group of 26 volunteers who meet the inclusion criteria of the study will form the control group. These participants will be given clinical routine training about mucositis care.
No interventions assigned to this group
Intervention Group
In the study, in order to prevent/minimize the flow of information between the control and intervention groups, the data of the control group will be collected first. Data collection will be suspended in the clinic for three months after the control group data is completed. After this period, data of the enterprise group will be collected. Participants in the intervention group will be provided with mucositis training within the scope of the Mucositis Care Protocol in line with the MASCC / ISOO 2019 Recommendations.
Mucositis care training to be given in line with MASCC / ISOO 2019
Mucositis care training to be given in line with MASCC / ISOO 2019
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mucositis care training to be given in line with MASCC / ISOO 2019
Mucositis care training to be given in line with MASCC / ISOO 2019
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient is followed up in the Pediatric Hematology Clinic
* The patient is only receiving leukaemia treatment
* The patient is receiving chemotherapy suitable for the high-risk group (T-ALL, High Risk ALL \[Protocol HR1-2-3\], Middle Risk ALL \[Protocol M, Mtx 5gr / m2\] The patient does not have any other chronic disease
* The patient does not have a systemic infection
* The patient has a central venous catheter or port catheter Volunteering of the mother and the caregiver parent
* The caring parent knows Turkish and is open to communication
Exclusion Criteria
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SEDA ARDAHAN SEVGİLİ
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SELMİN ŞENOL
Role: STUDY_CHAIR
KÜTAHYA UNIVERSITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University Hospital
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-6.1T/62
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.